Diabetes/ Healthcare/ US/ Views and analysis ADA preview: cardio data in diabetes, drug costs and healthcare reform Richard Staines ADA, ADA 2017, American Diabetes Association, cardiology, Diabetes, Janssen, Novo Nordisk 0 Comment Invokana data could suggest cardio benefit for SGLT2 class. Share X ADA preview: cardio data in diabetes, drug costs and healthcare reform https://pharmaphorum.com/views-and-analysis/ada-preview-new-cardio-data/